Practical Compliance. Real-World Ready.

Medical Devices

Pharmaceuticals

Combination Products

Biologics

Who We Are.

Trusted. Proven. Chosen.

With 20+ years of proven success and a roster of returning clients, QualityHub isn’t just experienced – we are experience, built on trust, results, and lasting relationships. We transform goals into outcomes and foster bonds that stand the test of time.

> Learn More

On-Demand Talent
for the Lifecycle of
Your Regulated Product.

Talent Categories
Product Development/R&D Quality Assurance Regulatory Affairs Manufacturing & Operations Supply Chain Clinical Program/Project Management

Product Development/R&D

When projects pile up and timelines tighten, QualityHub delivers product development and R&D professionals who keep things moving. Our experts plug in fast, bring fresh perspectives, and drive progress without missing a beat.

> Find out how QualityHub has your staffing needs covered for product development and R&D.

Quality Assurance

Need sharp, reliable QA talent – right now? QualityHub connects you with experienced Quality Assurance experts who hit the ground running. From audit prep to process validation, our professionals keep your quality system compliant, efficient, and stress-free.

> Find out how QualityHub has your QA staffing needs covered.

Regulatory Affairs

Regulatory challenges move fast, so make sure your team moves faster. QualityHub matches your company with longtime Regulatory Affairs pros who seamlessly integrate, tackle complex requirements, and keep your projects on track.

> Find out how QualityHub has your RA staffing needs covered.

Manufacturing & Operations

Need skilled manufacturing and operations experts who are ready on Day One? QualityHub delivers top-tier talent fast so you never miss a beat. Whether it’s ramping up production or creatively handling unexpected demands, our experts keep things running smoothly.

> Find out how QualityHub has your staffing needs covered for manufacturing and operations.

Supply Chain

Power your supply chain with seasoned experts who know the ropes and the regulations. At QualityHub, we connect you with top-tier professionals who don’t just understand supply chain challenges – they bring risk management, contingency plans, and resilience.

> Find out how QualityHub has staffing needs covered for your supply chain.

Clinical

QualityHub’s clinical pros understand regulated industry’s need for rigorous clinical data. Our carefully vetted professionals ensure compliance with requirements, appropriate study design, and clear interpretation of results, giving your company market authorization confidence and the highest standards of product quality and safety.

> Find out how QualityHub has your clinical staffing needs covered.

Program/Project Management

QualityHub experts bring clarity, compliance mastery, and relentless focus to the management of your regulated company’s programs and projects. They streamline workflows, minimize risks, and keep initiatives advancing and on target.

> Find out how QualityHub has your staffing needs covered for program and project management.

What Our Clients Say About Us.

"The FDA readiness training was tailored to our specific manufacturing site and incorporated local procedures and previous regulatory comments. This targeted approach yielded a greater training impact and understanding."
"The training we received from QualityHub FDA compliance consultants was invaluable in preparing the site for an inspection. This helped establish proper expectations and confidence. QualityHub provided excellent screening, guidance and training for the establishment of the staging room operations, scribes and inspection administrators."
"QualityHub's input in regard to inspection readiness has been very helpful in preparation for that success!"
"The FDA readiness training by QualityHub is a great refresher course. Take the time to polish up and improve your preparedness knowing their knowledge and expertise makes this a worthwhile practice."
"Thanks to QualityHub's input and the mock inspection, our improved tactics and inspection readiness activities really paid off."

Explore Our MediaHub

FDA Unveils Top 5 QMSR Inspection Findings as MedTech Firms Adjust to New Rule

Early FDA inspection data under the new QMSR framework points to persistent weaknesses in how companies manage risk, oversee suppliers, investigate complaints, maintain UDI compliance, and implement corrective actions. The findings highlight the agency’s increased focus on linking post-market data, supplier controls, and quality processes within a unified, risk-based system.

QHub Insights║What Facility Walkthroughs Reveal About Quality Culture

A strong Culture of Quality in medical device companies is demonstrated through leadership actions and employees’ willingness to raise concerns, among other factors, rather than through written policies alone. QHub SME Phil Parsons explains that developing this culture requires sustained leadership commitment, thoughtful hiring of quality-focused individuals, and time to build trust across teams.

FDA Unveils Top 5 QMSR Inspection Findings as MedTech Firms Adjust to New Rule

Early FDA inspection data under the new QMSR framework points to persistent weaknesses in how companies manage risk, oversee suppliers, investigate complaints, maintain UDI compliance, and implement corrective actions. The findings highlight the agency’s increased focus on linking post-market data, supplier controls, and quality processes within a unified, risk-based system.

QHub Insights║What Facility Walkthroughs Reveal About Quality Culture

A strong Culture of Quality in medical device companies is demonstrated through leadership actions and employees’ willingness to raise concerns, among other factors, rather than through written policies alone. QHub SME Phil Parsons explains that developing this culture requires sustained leadership commitment, thoughtful hiring of quality-focused individuals, and time to build trust across teams.

QHub Brief║Drug-Device Combination Products & QMSR Compliance: FDA Expectations for Device Constituent Parts

In this QualityHub Brief, pharma companies are introduced to the unique regulatory and manufacturing challenges associated with developing combination products, even when using standard delivery devices like prefilled syringes. The Brief highlights the importance of complying not only with traditional FDA drug regulations, but also with medical device design and manufacturing requirements.

CDRH Director: FDA Advances Expansion of At-Home Care as Device Innovation Grows

CDRH Director Michelle Tarver says the FDA is advancing a major push toward at-home healthcare as chronic disease rates rise, provider shortages grow, and medical device innovation accelerates. New technologies are enabling patients to monitor and manage conditions outside clinical settings, prompting the agency to expand support for digital health tools and streamline safety oversight.

MedCon 2026: FDA Official Reminds MedTechs They’re ‘Ultimately Responsible’ for Submitted Data

FDA official Josh Nipper warned medical device companies at MedCon that they remain fully accountable for the accuracy and integrity of all data submitted for regulatory review, even when using third-party testing labs. Data integrity issues trigger immediate negative decisions and have derailed submissions across multiple pathways, often at significant cost. The agency is signaling a stricter regulatory focus on end-to-end data oversight as device complexity continues to grow.

MedCon 2026: FDA Says Medical Device Inspectorate Builds on QSIT Legacy

FDA officials at MedCon 2026 said the agency’s new medical device inspection framework under the Quality Management System Regulation builds on the legacy of the Quality System Inspection Technique while emphasizing more standardized and comprehensive investigator training. They highlighted that training expanded across different FDA centers and has been underway since 2020, aiming to better prepare investigators for practical application and cross-functional oversight.

MedCon 2026: FDA Pressed on Review Timelines as Agency Official Acknowledges ‘Strain’

At MedCon 2026, FDA official Barb Marsden acknowledged growing strain on medical device review timelines driven by staffing shortages and MDUFA-related workload pressures, while stakeholders raised concerns about inconsistent deadline enforcement and emerging use of AI in reviews, with the agency emphasizing continued human accountability and efforts to improve transparency and process tracking.

QHub Insights║1 Year After Layoffs, FDA Stable but Faces Long Road to Rebuild Lost Expertise, Says Device Center Vet

One year after RIFs, the FDA has stabilized operationally but faces a prolonged challenge in rebuilding lost institutional knowledge and expertise, according to former official (and current QualityHub VP) Sean Boyd. While review performance remains strong and recovery efforts are underway, gaps in leadership, training, and experience will likely take years to fully address. Meanwhile, the departure of seasoned staff may be benefiting the broader medical device industry, as former regulators bring valuable insight into private-sector roles.

QualityHub Taps Former Zimmer Biomet, Baxter Healthcare Leader Christina Arnt as VP, Medical Device Compliance

QualityHub has appointed medical device quality executive Christina Arnt as Vice President of Medical Device Compliance. Arnt brings extensive global quality systems leadership experience from roles at Zimmer Biomet, Baxter Healthcare, and St. Jude Medical. At QualityHub, she’ll support manufacturers in strengthening regulatory readiness and improving compliance with FDA and global requirements.